A importância de superar a inércia terapêutica no tratamento da CMHo: Novos guidelines

A miocardiopatia hipertrófica (CMH) é a doença cardíaca genética mais comum, afetando pessoas de todas as idades e sendo uma das principais causas de morte súbita em jovens atletas. Com registros em 122 países, abrangendo 90% da população mundial, a CMH exige uma abordagem clínica eficaz para melhorar a qualidade de vida dos pacientes e reduzir os riscos associados. Confira esse e outros posts no Portal Afya e siga nossas redes sociais! FacebookInstagramLinkedinTwitter

Episode metadata supplied by the publisher feed · Published Jan 15, 2025

Embed this episode

Attribution link and audio player

Ready to play

A importância de superar a inércia terapêutica no tratamento da CMHo: Novos guidelines

0:00 16:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Afya Podcasts?

This episode is 16 minutes long.

When was this Afya Podcasts episode published?

This episode was published on January 15, 2025.

Can I download this Afya Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!